Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 388

1.

Evaluation of [68Ga]DO3A-VS-Cys40-Exendin-4 as a PET Probe for Imaging Human Transplanted Islets in the Liver.

Li J, Rawson J, Chea J, Tang W, Miao L, Sui F, Li L, Poku E, Shively JE, Kandeel F.

Sci Rep. 2019 Apr 5;9(1):5705. doi: 10.1038/s41598-019-42172-3.

2.

CEACAM1 regulates the IL-6 mediated fever response to LPS through the RP105 receptor in murine monocytes.

Zhang Z, La Placa D, Nguyen T, Kujawski M, Le K, Li L, Shively JE.

BMC Immunol. 2019 Jan 23;20(1):7. doi: 10.1186/s12865-019-0287-y.

3.

NMR analysis of free and lipid nanodisc anchored CEACAM1 membrane proximal peptides with Ca2+/CaM.

Ghazarian H, Hu W, Mao A, Nguyen T, Vaidehi N, Sligar S, Shively JE.

Biochim Biophys Acta Biomembr. 2019 Apr 1;1861(4):787-797. doi: 10.1016/j.bbamem.2019.01.004. Epub 2019 Jan 10.

PMID:
30639287
4.

Functional Imaging of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancers and a Note about NOTA.

Mortimer JE, Shively JE.

J Nucl Med. 2019 Jan;60(1):23-25. doi: 10.2967/jnumed.118.220905. Epub 2018 Dec 20. No abstract available.

PMID:
30573641
5.

SNPs in inflammatory genes CCL11, CCL4 and MEFV in a fibromyalgia family study.

Zhang Z, Feng J, Mao A, Le K, La Placa D, Wu X, Longmate J, Marek C, St Amand RP, Neuhausen SL, Shively JE.

PLoS One. 2018 Jun 21;13(6):e0198625. doi: 10.1371/journal.pone.0198625. eCollection 2018.

6.

Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cells.

Abdul-Wahid A, Cydzik M, Fischer NW, Prodeus A, Shively JE, Martel A, Alminawi S, Ghorab Z, Berinstein NL, Gariépy J.

Int J Cancer. 2018 Oct 15;143(8):1963-1977. doi: 10.1002/ijc.31586. Epub 2018 Aug 9.

7.

PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with 89Zr-Oxine.

Weist MR, Starr R, Aguilar B, Chea J, Miles JK, Poku E, Gerdts E, Yang X, Priceman SJ, Forman SJ, Colcher D, Brown CE, Shively JE.

J Nucl Med. 2018 Oct;59(10):1531-1537. doi: 10.2967/jnumed.117.206714. Epub 2018 May 4.

8.

Interferon regulatory factor 1 and a variant of heterogeneous nuclear ribonucleoprotein L coordinately silence the gene for adhesion protein CEACAM1.

Dery KJ, Silver C, Yang L, Shively JE.

J Biol Chem. 2018 Jun 15;293(24):9277-9291. doi: 10.1074/jbc.RA117.001507. Epub 2018 May 2.

9.

CEACAM1 is associated with recurrence after hepatectomy for colorectal liver metastasis.

Yamaguchi S, Yokoyama S, Ueno M, Hayami S, Mitani Y, Takeuchi A, Shively JE, Yamaue H.

J Surg Res. 2017 Dec;220:353-362. doi: 10.1016/j.jss.2017.07.035. Epub 2017 Aug 21.

PMID:
29180203
10.

Synthesis, Positron Emission Tomography Imaging, and Therapy of Diabody Targeted Drug Lipid Nanoparticles in a Prostate Cancer Murine Model.

Wong P, Li L, Chea J, Delgado MK, Poku E, Szpikowska B, Bowles N, Minnix M, Colcher D, Wong JYC, Shively JE, Yazaki PJ.

Cancer Biother Radiopharm. 2017 Sep;32(7):247-257.

11.

The adaptor SASH1 acts through NOTCH1 and its inhibitor DLK1 in a 3D model of lumenogenesis involving CEACAM1.

Stubblefield K, Chean J, Nguyen T, Chen CJ, Shively JE.

Exp Cell Res. 2017 Oct 15;359(2):384-393. doi: 10.1016/j.yexcr.2017.08.022. Epub 2017 Aug 18.

PMID:
28823832
12.

Clinical implications of carcinoembryonic antigen distribution in serum exosomal fraction-Measurement by ELISA.

Yokoyama S, Takeuchi A, Yamaguchi S, Mitani Y, Watanabe T, Matsuda K, Hotta T, Shively JE, Yamaue H.

PLoS One. 2017 Aug 17;12(8):e0183337. doi: 10.1371/journal.pone.0183337. eCollection 2017.

13.

ETS transcription factor ELF5 induces lumen formation in a 3D model of mammary morphogenesis and its expression is inhibited by Jak2 inhibitor TG101348.

Chean J, Chen CJ, Shively JE.

Exp Cell Res. 2017 Oct 1;359(1):62-75. doi: 10.1016/j.yexcr.2017.08.008. Epub 2017 Aug 8.

PMID:
28800960
14.

Tumor Uptake of 64Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer.

Mortimer JE, Bading JR, Park JM, Frankel PH, Carroll MI, Tran TT, Poku EK, Rockne RC, Raubitschek AA, Shively JE, Colcher DM.

J Nucl Med. 2018 Jan;59(1):38-43. doi: 10.2967/jnumed.117.193888. Epub 2017 Jun 21. Erratum in: J Nucl Med. 2018 Feb;59(2):346.

15.

Characterization of 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[Methoxy(polyethylene glycerol)-2000] and Its Complex with Doxorubicin Using Nuclear Magnetic Resonance Spectroscopy and Molecular Dynamics.

Hu W, Mao A, Wong P, Larsen A, Yazaki PJ, Wong JYC, Shively JE.

Bioconjug Chem. 2017 Jun 21;28(6):1777-1790. doi: 10.1021/acs.bioconjchem.7b00238. Epub 2017 Jun 9.

PMID:
28520406
16.

Diagnostic PET Imaging of Mammary Microcalcifications Using 64Cu-DOTA-Alendronate in a Rat Model of Breast Cancer.

Ahrens BJ, Li L, Ciminera AK, Chea J, Poku E, Bading JR, Weist MR, Miller MM, Colcher DM, Shively JE.

J Nucl Med. 2017 Sep;58(9):1373-1379. doi: 10.2967/jnumed.117.190850. Epub 2017 Apr 27.

17.

CAMK2γ in intestinal epithelial cells modulates colitis-associated colorectal carcinogenesis via enhancing STAT3 activation.

Ma X, Meng Z, Jin L, Xiao Z, Wang X, Tsark WM, Ding L, Gu Y, Zhang J, Kim B, He M, Gan X, Shively JE, Yu H, Xu R, Huang W.

Oncogene. 2017 Jul 13;36(28):4060-4071. doi: 10.1038/onc.2017.16. Epub 2017 Mar 20.

18.

PET imaging of 64Cu-DOTA-scFv-anti-PSMA lipid nanoparticles (LNPs): Enhanced tumor targeting over anti-PSMA scFv or untargeted LNPs.

Wong P, Li L, Chea J, Delgado MK, Crow D, Poku E, Szpikowska B, Bowles N, Channappa D, Colcher D, Wong JYC, Shively JE, Yazaki PJ.

Nucl Med Biol. 2017 Apr;47:62-68. doi: 10.1016/j.nucmedbio.2017.01.004. Epub 2017 Jan 17.

19.

miRNA-342 Regulates CEACAM1-induced Lumen Formation in a Three-dimensional Model of Mammary Gland Morphogenesis.

Weng C, Nguyen T, Shively JE.

J Biol Chem. 2016 Aug 5;291(32):16777-86. doi: 10.1074/jbc.M115.710152. Epub 2016 Jun 14.

20.
21.

Induction of antigen-specific TH 9 immunity accompanied by mast cell activation blocks tumor cell engraftment.

Abdul-Wahid A, Cydzik M, Prodeus A, Alwash M, Stanojcic M, Thompson M, Huang EH, Shively JE, Gray-Owen SD, Gariépy J.

Int J Cancer. 2016 Aug 15;139(4):841-53. doi: 10.1002/ijc.30121. Epub 2016 Apr 15.

22.

P4H9-detected molecule expression on spindle-shaped fibroblasts indicates malignant phenotype of colorectal cancer.

Yokoyama S, Ieda J, Yamamoto N, Yamaguchi S, Mitani Y, Takeuchi A, Takifuji K, Hotta T, Matsuda K, Watanabe T, Shively JE, Yamaue H.

Br J Cancer. 2015 Nov 17;113(10):1454-9. doi: 10.1038/bjc.2015.363. Epub 2015 Oct 15.

23.

CEACAM1 and hollow spheroid formation modulate the chemosensitivity of colorectal cancer to 5-fluorouracil.

Yamamoto N, Yokoyama S, Ieda J, Mitani Y, Yamaguchi S, Takifuji K, Hotta T, Matsuda K, Watanabe T, Shively JE, Yamaue H.

Cancer Chemother Pharmacol. 2015 Feb;75(2):421-30. doi: 10.1007/s00280-014-2662-y. Epub 2014 Dec 30.

PMID:
25547406
24.

Radioimmunoimaging of liver metastases with PET using a 64Cu-labeled CEA antibody in transgenic mice.

Nittka S, Krueger MA, Shively JE, Boll H, Brockmann MA, Doyon F, Pichler BJ, Neumaier M.

PLoS One. 2014 Sep 16;9(9):e106921. doi: 10.1371/journal.pone.0106921. eCollection 2014.

25.

Sequence analysis and feeding responses evoked by the large molecular form of gastrin releasing peptide (GRP) in the rat GRP-29.

Reeve JR Jr, Washington MC, Park KH, Johnson T, Hunt J, Shively JE, Ronk M, Lee TD, Goto Y, Chew P, Ho FJ, Sayegh AI.

Peptides. 2014 Sep;59:1-8. doi: 10.1016/j.peptides.2014.06.013. Epub 2014 Jun 30.

PMID:
24993846
26.

(64)Cu labeled sarcophagine exendin-4 for microPET imaging of glucagon like peptide-1 receptor expression.

Wu Z, Liu S, Nair I, Omori K, Scott S, Todorov I, Shively JE, Conti PS, Li Z, Kandeel F.

Theranostics. 2014 May 24;4(8):770-7. doi: 10.7150/thno.7759. eCollection 2014.

27.

Facile Preparation of a Thiol-Reactive (18)F-Labeling Agent and Synthesis of (18)F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor-Positive Tumor.

Wu Z, Li L, Liu S, Yakushijin F, Yakushijin K, Horne D, Conti PS, Li Z, Kandeel F, Shively JE.

J Nucl Med. 2014 Jul;55(7):1178-84. doi: 10.2967/jnumed.114.137489. Epub 2014 May 22.

28.
29.

CEACAM1 long cytoplasmic domain isoform is associated with invasion and recurrence of hepatocellular carcinoma.

Kiriyama S, Yokoyama S, Ueno M, Hayami S, Ieda J, Yamamoto N, Yamaguchi S, Mitani Y, Nakamura Y, Tani M, Mishra L, Shively JE, Yamaue H.

Ann Surg Oncol. 2014 Dec;21 Suppl 4:S505-14. doi: 10.1245/s10434-013-3460-1. Epub 2014 Jan 6.

30.

Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET.

Mortimer JE, Bading JR, Colcher DM, Conti PS, Frankel PH, Carroll MI, Tong S, Poku E, Miles JK, Shively JE, Raubitschek AA.

J Nucl Med. 2014 Jan;55(1):23-9. doi: 10.2967/jnumed.113.122630. Epub 2013 Dec 12.

31.

Phosphorylation of CEACAM1 molecule by calmodulin kinase IID in a three-dimensional model of mammary gland lumen formation.

Nguyen T, Chen CJ, Shively JE.

J Biol Chem. 2014 Jan 31;289(5):2934-45. doi: 10.1074/jbc.M113.496992. Epub 2013 Dec 3.

32.

In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa.

Johswich KO, McCaw SE, Islam E, Sintsova A, Gu A, Shively JE, Gray-Owen SD.

PLoS Pathog. 2013;9(7):e1003509. doi: 10.1371/journal.ppat.1003509. Epub 2013 Jul 25.

33.

Acceleration of bone repair in NOD/SCID mice by human monoosteophils, novel LL-37-activated monocytes.

Zhang Z, Shively JE.

PLoS One. 2013 Jul 3;8(7):e67649. doi: 10.1371/journal.pone.0067649. Print 2013.

34.

Discovery of potential new gene variants and inflammatory cytokine associations with fibromyalgia syndrome by whole exome sequencing.

Feng J, Zhang Z, Wu X, Mao A, Chang F, Deng X, Gao H, Ouyang C, Dery KJ, Le K, Longmate J, Marek C, St Amand RP, Krontiris TG, Shively JE.

PLoS One. 2013 Jun 10;8(6):e65033. doi: 10.1371/journal.pone.0065033. Print 2013.

35.

The systemic cytokine environment is permanently altered in multiple myeloma.

Zheng MM, Zhang Z, Bemis K, Belch AR, Pilarski LM, Shively JE, Kirshner J.

PLoS One. 2013;8(3):e58504. doi: 10.1371/journal.pone.0058504. Epub 2013 Mar 27.

36.

CEACAM1 regulates Fas-mediated apoptosis in Jurkat T-cells via its interaction with β-catenin.

Li Y, Shively JE.

Exp Cell Res. 2013 May 1;319(8):1061-72. doi: 10.1016/j.yexcr.2013.02.020. Epub 2013 Mar 7.

37.

Role of CEACAM1 and CEACAM20 in an in vitro model of prostate morphogenesis.

Zhang H, Eisenried A, Zimmermann W, Shively JE.

PLoS One. 2013;8(1):e53359. doi: 10.1371/journal.pone.0053359. Epub 2013 Jan 24.

38.
39.

Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets.

Wu Z, Liu S, Hassink M, Nair I, Park R, Li L, Todorov I, Fox JM, Li Z, Shively JE, Conti PS, Kandeel F.

J Nucl Med. 2013 Feb;54(2):244-51. doi: 10.2967/jnumed.112.109694. Epub 2013 Jan 7.

40.

A series of anti-CEA/anti-DOTA bispecific antibody formats evaluated for pre-targeting: comparison of tumor uptake and blood clearance.

Yazaki PJ, Lee B, Channappa D, Cheung CW, Crow D, Chea J, Poku E, Li L, Andersen JT, Sandlie I, Orcutt KD, Wittrup KD, Shively JE, Raubitschek A, Colcher D.

Protein Eng Des Sel. 2013 Mar;26(3):187-93. doi: 10.1093/protein/gzs096. Epub 2012 Nov 21.

41.

The short isoform of the CEACAM1 receptor in intestinal T cells regulates mucosal immunity and homeostasis via Tfh cell induction.

Chen L, Chen Z, Baker K, Halvorsen EM, da Cunha AP, Flak MB, Gerber G, Huang YH, Hosomi S, Arthur JC, Dery KJ, Nagaishi T, Beauchemin N, Holmes KV, Ho JW, Shively JE, Jobin C, Onderdonk AB, Bry L, Weiner HL, Higgins DE, Blumberg RS.

Immunity. 2012 Nov 16;37(5):930-46. doi: 10.1016/j.immuni.2012.07.016. Epub 2012 Nov 1.

42.

CEACAM1 negatively regulates IL-1β production in LPS activated neutrophils by recruiting SHP-1 to a SYK-TLR4-CEACAM1 complex.

Lu R, Pan H, Shively JE.

PLoS Pathog. 2012;8(4):e1002597. doi: 10.1371/journal.ppat.1002597. Epub 2012 Apr 5.

43.

Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1.

Lu R, Kujawski M, Pan H, Shively JE.

Cancer Res. 2012 May 1;72(9):2239-50. doi: 10.1158/0008-5472.CAN-11-3016. Epub 2012 Mar 9. Erratum in: Cancer Res. 2016 Feb 15;76(4):984-5.

44.

Role of CEACAM1, ECM, and mesenchymal stem cells in an orthotopic model of human breast cancer.

Samineni S, Glackin C, Shively JE.

Int J Breast Cancer. 2011;2011:381080. doi: 10.4061/2011/381080. Epub 2010 Nov 7. Erratum in: Int J Breast Cancer. 2011;2011:537380.

45.

Hollow spheroids beyond the invasive margin indicate the malignant potential of colorectal cancer.

Tamura K, Yokoyama S, Ieda J, Takifuji K, Hotta T, Matsuda K, Oku Y, Watanabe T, Nasu T, Kiriyama S, Yamamoto N, Nakamura Y, Shively JE, Yamaue H.

BMJ Open. 2011 Aug 11;1(1):e000179. doi: 10.1136/bmjopen-2011-000179.

46.
47.

In vivo imaging of transplanted islets with 64Cu-DO3A-VS-Cys40-Exendin-4 by targeting GLP-1 receptor.

Wu Z, Todorov I, Li L, Bading JR, Li Z, Nair I, Ishiyama K, Colcher D, Conti PE, Fraser SE, Shively JE, Kandeel F.

Bioconjug Chem. 2011 Aug 17;22(8):1587-94. doi: 10.1021/bc200132t. Epub 2011 Jul 14.

PMID:
21692471
48.

Interaction of actin with carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) receptor in liposomes is Ca2+- and phospholipid-dependent.

Lu R, Niesen MJ, Hu W, Vaidehi N, Shively JE.

J Biol Chem. 2011 Aug 5;286(31):27528-36. doi: 10.1074/jbc.M111.235762. Epub 2011 Jun 13.

49.

Re-expression of CEACAM1 long cytoplasmic domain isoform is associated with invasion and migration of colorectal cancer.

Ieda J, Yokoyama S, Tamura K, Takifuji K, Hotta T, Matsuda K, Oku Y, Nasu T, Kiriyama S, Yamamoto N, Nakamura Y, Shively JE, Yamaue H.

Int J Cancer. 2011 Sep 15;129(6):1351-61. doi: 10.1002/ijc.26072. Epub 2011 May 25.

50.

Mechanistic control of carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) splice isoforms by the heterogeneous nuclear ribonuclear proteins hnRNP L, hnRNP A1, and hnRNP M.

Dery KJ, Gaur S, Gencheva M, Yen Y, Shively JE, Gaur RK.

J Biol Chem. 2011 May 6;286(18):16039-51. doi: 10.1074/jbc.M110.204057. Epub 2011 Mar 11.

Supplemental Content

Loading ...
Support Center